Janetka receives NIH grant to study inhibitors of pro-HGF activation

Jim Janetka, associate professor of biochemistry and molecular biophysics at the School of Medicine, received a one-year SBIR grant award totaling $299,972 from the National Cancer Institute of the National Institutes of Health (NIH) for research titled “Inhibitors of pro-HGF activation overcome resistance to anti-EGFR therapy.”

Leave a Comment

Comments and respectful dialogue are encouraged, but content will be moderated. Please, no personal attacks, obscenity or profanity, selling of commercial products, or endorsements of political candidates or positions. We reserve the right to remove any inappropriate comments. We also cannot address individual medical concerns or provide medical advice in this forum.